Somatostatin receptor expression indicates improved prognosis in gastroenteropancreatic neuroendocrine neoplasm, and octreotide long-acting release is effective and safe in Chinese patients with advanced gastroenteropancreatic neuroendocrine tumors

Gastroenteropancreatic neuroendocrine neoplasm (GEP-NEN) is known to overexpress somatostatin receptors (SSTRs), most commonly SSTR2 and SSTR5. The expression of SSTRs on tumor cells forms the basis for somatostatin analog treatment of patients with NEN. The present study detected the expression of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuhong, Wang, Wei, Jin, Kaizhou, Fang, Cheng, Lin, Yuan, Xue, Ling, Feng, Shiting, Zhou, Zhiwei, Shao, Chenghao, Chen, Minhu, Yu, Xianjun, Chen, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403486/
https://www.ncbi.nlm.nih.gov/pubmed/28454229
http://dx.doi.org/10.3892/ol.2017.5591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403486/
https://www.ncbi.nlm.nih.gov/pubmed/28454229
http://dx.doi.org/10.3892/ol.2017.5591

Ejemplares similares